WOOJUNG BIO, Inc. (KOSDAQ:215380)
South Korea · Delayed Price · Currency is KRW 1,743.00
-76.00 (-4.18%)
At close: Jul 18, 2025, 3:30 PM KST
WOOJUNG BIO Revenue
WOOJUNG BIO had revenue of 8.31B KRW in the quarter ending March 31, 2025, a decrease of -18.16%. This brings the company's revenue in the last twelve months to 41.36B, up 1.69% year-over-year. In the year 2024, WOOJUNG BIO had annual revenue of 43.20B with 11.87% growth.
Revenue (ttm)
41.36B
Revenue Growth
+1.69%
P/S Ratio
0.71
Revenue / Employee
n/a
Employees
n/a
Market Cap
29.33B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 43.20B | 4.58B | 11.87% |
| Dec 31, 2023 | 38.62B | -8.30B | -17.70% |
| Dec 31, 2022 | 46.92B | 15.68B | 50.20% |
| Dec 31, 2021 | 31.24B | -6.11B | -16.35% |
| Dec 31, 2020 | 37.34B | 5.05B | 15.65% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 308.10T |
| SK hynix | 71.40T |
| Samsung Biologics | 4,898.69B |
| LG Energy Solution | 25.76T |
| Hyundai Motor Company | 178.98T |
| Hanwha Aerospace | 15.28T |
| Doosan Enerbility | 15.88T |
| KB Financial Group | 14.93T |